临床存在的问题目前临床上已开展对曾发生过短暂脑血流紊乱或卒中的患者行药物二级预防治疗。也就是用血小板功能抑制剂(TFH)或抗凝剂,以阻止卒中或心肌梗塞再发,此外,也须治疗引起卒中的主要危险因素高血压。大样本随机临床研究表明,TFH 可预防短暂性脑缺血发生(TIA)或卒中的复发。它可使血管性疾患如心肌梗塞、卒中或血管性死亡等的发生减少 The clinical problems Currently clinically carried out for patients with transient cerebral blood flow disorder or stroke in patients with drug secondary prevention and treatment. That is, with platelet function inhibitors (TFH) or anticoagulants to prevent the recurrence of stroke or myocardial infarction, in addition, the main risk factors for stroke caused by hypertension should be treated. Large randomized clinical studies have shown that TFH can prevent the occurrence of transient ischemic attack (TIA) or stroke recurrence. It can reduce the incidence of vascular disorders such as myocardial infarction, stroke or vascular death